YELLOW FEVER
Clinical trials for YELLOW FEVER explained in plain language.
Never miss a new study
Get alerted when new YELLOW FEVER trials appear
Sign up with your email to follow new studies for YELLOW FEVER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New vaccines for yellow fever and rabies enter first human tests
⭐️ VACCINE ⭐️ CompletedThis early-stage trial tested two new vaccines—one for yellow fever and one for rabies—in 112 healthy adults aged 18 to 40. The main goal was to check safety and see how well the vaccines trigger an immune response. Participants received different doses or a placebo to help find …
Matched conditions: YELLOW FEVER
Phase: PHASE1 • Sponsor: AstriVax Therapeutics • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 12:23 UTC
-
New yellow fever vaccine shows promise in early human trial
⭐️ VACCINE ⭐️ CompletedThis early-stage study tested a new yellow fever vaccine (MVA-BN-YF) in 92 healthy adults aged 18-45. Some volunteers received the vaccine alone, some with an adjuvant (ISA 720) to boost the immune response, and others received a placebo or a different vaccine. The main goal was …
Matched conditions: YELLOW FEVER
Phase: PHASE1 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 09:03 UTC
-
New yellow fever vaccine shows promise in japanese adults
⭐️ VACCINE ⭐️ CompletedThis study tested a yellow fever vaccine in 254 healthy adults aged 18 and older in Japan. Participants received one shot under the skin and were followed for about a month. The goal was to see if the vaccine triggers a strong immune response and is safe.
Matched conditions: YELLOW FEVER
Phase: PHASE3 • Sponsor: Sanofi Pasteur, a Sanofi Company • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 09:01 UTC
-
New yellow fever vaccine shows promise in early safety trial
⭐️ VACCINE ⭐️ CompletedThis Phase 1 trial tested an inactivated yellow fever vaccine called HydroVax-002 YFV in 26 healthy adults. Participants received two doses of either the vaccine or a placebo. The main goal was to check safety and side effects, while also measuring immune response. The trial is c…
Matched conditions: YELLOW FEVER
Phase: PHASE1 • Sponsor: Najit Technologies, Inc. • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 26, 2026 18:43 UTC
-
Scientists probe why some vaccines fade: lymph node damage may be key
Knowledge-focused CompletedThis study looked at how past infections and damage to lymph node structures might weaken the body's long-term immune response to the yellow fever vaccine. Researchers enrolled 43 healthy adults in Uganda and Minnesota, collecting blood and lymph node samples before and after vac…
Matched conditions: YELLOW FEVER
Phase: PHASE1, PHASE2 • Sponsor: University of Minnesota • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:53 UTC
-
Scientists use yellow fever vaccine to map immune System's battle plan
Knowledge-focused CompletedThis study gave 239 healthy adults the yellow fever vaccine to learn how the immune system fights viral infections. Researchers measured the strength and quality of T cell responses over up to one year. The goal was to understand immune reactions, not to test the vaccine itself, …
Matched conditions: YELLOW FEVER
Phase: PHASE4 • Sponsor: Emory University • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:53 UTC